AVENUE THERAPEUTICS INC (ATXI) Stock Analyst Earnings Estimates
NASDAQ:ATXI - Nasdaq - US05360L4032 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | ||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.843M | -2.377M 50.92% | -11.421M -380.48% | -21.816M -91.02% | -26.265M -20.39% | -5.213M 80.15% | -3.738M 28.29% | -8.043M -115.17% | -14.54M -80.78% | N/A 13.81% | N/A -15.54% | N/A -18.11% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -1,935.00 21.93% | -348.75 81.98% | N/A | N/A | -131.25 19.07% | N/A 95.15% | N/A 68.59% | N/A 6.12% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -1.02 -122.67% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -3.162M -49.22% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.92 -142.67% | -0.96 | -0.96 | -100.25% |
| Q2 2024 Q2Q % growth | -6.43 83.51% | -1.07 | -5.36 | -500.37% |
| Q1 2024 Q2Q % growth | -15.40 84.79% | -9.18 | -6.22 | -67.76% |
| Q4 2023 Q2Q % growth | 4.50 -76.92% | -7.65 | 12.15 | 158.82% |
| Q3 2023 Q2Q % growth | 4.50 1,100.00% | -19.89 | 24.39 | 122.62% |
| Q2 2023 Q2Q % growth | -39.00 | -22.19 | -16.82 | -75.79% |
| Q1 2023 Q2Q % growth | -101.25 | -9.95 | -91.31 | -918.10% |
| Q4 2022 Q2Q % growth | 19.50 | -11.48 | 30.98 | 269.93% |
| Q3 2022 Q2Q % growth | -0.45 99.20% | % | ||
| Q3 2021 Q2Q % growth | -56.25 16.67% | -57.38 | 1.13 | 1.96% |
| Q2 2021 Q2Q % growth | -67.50 45.45% | -68.85 | 1.35 | 1.96% |
| Q1 2021 Q2Q % growth | -67.50 25.00% | -68.85 | 1.35 | 1.96% |
| Q4 2020 Q2Q % growth | -67.50 81.82% | -68.85 | 1.35 | 1.96% |
| Q3 2020 Q2Q % growth | -67.50 57.14% | -114.75 | 47.25 | 41.18% |
| Q2 2020 Q2Q % growth | -123.75 74.42% | -120.49 | -3.26 | -2.71% |
| Q1 2020 Q2Q % growth | -90.00 90.24% | -200.81 | 110.81 | 55.18% |
| Q4 2019 Q2Q % growth | -371.25 | -327.04 | -44.21 | -13.52% |
| Q3 2019 Q2Q % growth | -157.50 | -325.12 | 167.62 | 51.56% |
| Q2 2019 Q2Q % growth | -483.75 | -550.80 | 67.05 | 12.17% |
| Q1 2019 Q2Q % growth | -922.50 | -493.43 | -429.08 | -86.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1011.11% | 0% | 1.89% |
| Revenue | N/A | N/A | N/A | N/A |